Prospective Testing For Pik3ca/Akt1/Pten Alterations In Tumor Tissue From 1440 Patients With Advanced Hormone Receptor-Positive Her2-Negative Breast Cancer (Hr+/Her2-Bc) Or Triple-Negative Breast Cancer (Tnbc) Screened For The Ipatunity130 Randomized Phase 3 Trial

CANCER RESEARCH(2021)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要